LifeMD will report Q2 2025 financial results and host a conference call on August 5, 2025.
Quiver AI Summary
LifeMD, Inc. will announce its financial results for the second quarter and the first half of 2025 on August 5, 2025, after the U.S. markets close. A conference call will follow at 4:30 p.m. Eastern time, with both toll-free and international dial-in options available for participants. LifeMD, a provider of virtual primary care services, utilizes a proprietary digital care platform and has a nationwide network, offering telemedicine and various health services across over 200 conditions, including primary care and specialized treatments. For further details, interested parties can visit their website or contact the investor and media relations representatives provided in the announcement.
Potential Positives
- Upcoming financial results reporting will provide transparency and insight into the company's performance, potentially building investor confidence.
- The scheduled conference call allows for direct communication with investors and stakeholders, offering a platform for discussion and engagement.
- LifeMD's established position as a leading provider of virtual primary care services highlights its competitive advantage in the growing telehealth market.
- The company's extensive service offerings and integrated care platform may enhance customer satisfaction and retention, supporting long-term growth.
Potential Negatives
- Potential concerns regarding financial performance are raised due to the company's scheduled financial report for the second quarter, suggesting a lack of confidence in current operational results.
- The announcement of the upcoming financial results indicates that the company is in a reporting phase, which could imply previous challenges in meeting financial expectations.
FAQ
When will LifeMD announce its financial results for Q2 2025?
LifeMD will report its financial results for the three and six months ended June 30, 2025, on August 5, 2025.
What time is the LifeMD conference call on August 5, 2025?
The LifeMD conference call will begin at 4:30 p.m. Eastern time on August 5, 2025.
How can I access the LifeMD conference call?
You can access the LifeMD conference call by dialing 800-445-7795 (toll-free) or 785-424-1699 (international).
What services does LifeMD offer?
LifeMD offers virtual primary care, telemedicine, laboratory and pharmacy services, and treatment across more than 200 medical conditions.
Where can I find more information about LifeMD?
For more information about LifeMD, please visit their official website at LifeMD.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$LFMD Insider Trading Activity
$LFMD insiders have traded $LFMD stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $LFMD stock by insiders over the last 6 months:
- MARC DAVID BENATHEN (Chief Financial Officer) has made 0 purchases and 2 sales selling 125,000 shares for an estimated $1,682,440.
- JUSTIN SCHREIBER (Chairman and CEO) has made 0 purchases and 6 sales selling 175,000 shares for an estimated $1,600,995.
- STEFAN GALLUPPI (Chief Innovation Officer) sold 85,000 shares for an estimated $1,052,657
- ERIC HAROLD YECIES (Chief Legal Officer & GC) sold 15,000 shares for an estimated $183,750
- JESSICA FRIEDEMAN (Chief Marketing Officer) sold 30,000 shares for an estimated $169,665
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LFMD Hedge Fund Activity
We have seen 53 institutional investors add shares of $LFMD stock to their portfolio, and 55 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- D. E. SHAW & CO., INC. added 417,403 shares (+263.5%) to their portfolio in Q1 2025, for an estimated $2,270,672
- CITADEL ADVISORS LLC added 411,865 shares (+561.8%) to their portfolio in Q1 2025, for an estimated $2,240,545
- MILLENNIUM MANAGEMENT LLC removed 409,525 shares (-46.2%) from their portfolio in Q1 2025, for an estimated $2,227,816
- MORGAN STANLEY added 327,330 shares (+78.2%) to their portfolio in Q1 2025, for an estimated $1,780,675
- QUBE RESEARCH & TECHNOLOGIES LTD removed 244,930 shares (-75.5%) from their portfolio in Q1 2025, for an estimated $1,332,419
- GOLDMAN SACHS GROUP INC removed 244,145 shares (-59.6%) from their portfolio in Q1 2025, for an estimated $1,328,148
- UBS GROUP AG removed 167,021 shares (-68.2%) from their portfolio in Q1 2025, for an estimated $908,594
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$LFMD Analyst Ratings
Wall Street analysts have issued reports on $LFMD in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Lake Street issued a "Buy" rating on 07/10/2025
- HC Wainwright & Co. issued a "Buy" rating on 04/30/2025
- Cantor Fitzgerald issued a "Overweight" rating on 03/11/2025
To track analyst ratings and price targets for $LFMD, check out Quiver Quantitative's $LFMD forecast page.
$LFMD Price Targets
Multiple analysts have issued price targets for $LFMD recently. We have seen 4 analysts offer price targets for $LFMD in the last 6 months, with a median target of $14.5.
Here are some recent targets:
- Aleksey Yefremov from Keybanc set a target price of $14.0 on 07/14/2025
- Brooks O'Neil from Lake Street set a target price of $18.0 on 07/10/2025
- Yi Chen from HC Wainwright & Co. set a target price of $14.0 on 04/30/2025
- Sarah James from Cantor Fitzgerald set a target price of $15.0 on 03/11/2025
Full Release
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD) , a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on August 5, 2025, and will host a conference call beginning at 4:30 p.m. Eastern time.
Conference Call & Webcast Details
| Date: | Tuesday, August 5 th |
| Time: | 4:30 p.m. Eastern time |
| Toll-Free Dial-In: | 800-445-7795 |
| International Dial-In: | 785-424-1699 |
| Conference ID: | LIFEMD |
| Live & Archived Webcast: | Link |
About LifeMD, Inc.
LifeMD ® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a 22,500-square-foot affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com .
Investor Contact
Marc Benathen, Chief Financial Officer
[email protected]
Media Contact
Jessica Friedeman, Chief Marketing Officer
[email protected]
